Atomi Financial Group’s AstraZeneca AZN Stock Holding History

Atomi Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.83M	Sell	14,917 -3,653	-20%	-$687K	0.07%	199
2026 Q1	$3.66M	Sell	18,570 -2,722	-13%	-$525K	0.11%	145
2025 Q4	$3.91M	Buy	21,292 +4,828	+29%	+$847K	0.11%	140
2025 Q3	$2.53M	Buy	16,464 +4,507	+38%	+$682K	0.08%	167
2025 Q2	$1.67M	Sell	11,957 -6,030	-34%	-$845K	0.06%	215
2025 Q1	$2.64M	Buy	17,987 +8,633	+92%	+$1.25M	0.12%	134
2024 Q4	$1.23M	Sell	9,354 -4,564	-33%	-$639K	0.06%	221
2024 Q3	$2.17M	Buy	13,918 +3,016	+28%	+$487K	0.14%	124
2024 Q2	$1.7M	Buy	10,902 +3,754	+53%	+$565K	0.13%	134
2024 Q1	$969K	Buy	7,148 +2,086	+41%	+$276K	0.09%	187
2023 Q4	$682K	Buy	+5,062	New	+$658K	0.09%	196

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Atomi Financial Group's AZN Position: Q2 2026 in Review

Atomi Financial Group reduced its AstraZeneca (AZN) stake by 20% in Q2 2026, selling an estimated $687K and leaving 14,917 shares worth $2.83M. The position accounts for 0.07% of the portfolio, ranked #199.

Atomi Financial Group first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.91M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Atomi Financial Group held 14,917 shares of AstraZeneca worth $2.83M as of Q2 2026.
Atomi Financial Group sold 3,653 AstraZeneca shares in Q2 2026, an estimated $687K.
AstraZeneca made up 0.07% of Atomi Financial Group's portfolio in Q2 2026, its #199 holding.
Atomi Financial Group first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Atomi Financial Group's AstraZeneca position peaked at $3.91M in Q4 2025.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.